Neuropace Inc (NPCE)

09:40 AM

Wall Street analysts see a 41.29% upside in NeuroPace (NPCE): Can the stock really move this high? - MSN

09:40 AM

05:21 AM

Here's why you should add NeuroPace stock to your portfolio now - MSN

05:21 AM

Apr 05, 2026

NeuroPace (NPCE) up 0.9% since last earnings report: Can it continue? - MSN

Apr 05, 2026

Apr 02, 2026

NeuroPace, Inc. (NPCE) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026

Apr 02, 2026

NeuroPace Earnings Call Highlights Growth And AI Push - The Globe and Mail

Apr 02, 2026

Apr 02, 2026

Here’s why investing in NeuroPace shares could be a smart addition to your portfolio at this time - Bitget

Apr 02, 2026

Apr 02, 2026

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now - Zacks Investment Research

Apr 02, 2026

Apr 02, 2026

NeuroPace (NPCE) Up 0.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Wall Street Analysts See a 41.29% Upside in NeuroPace (NPCE): Can the Stock Really Move This High? - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Wall Street experts predict NeuroPace (NPCE) could climb 41.29%: Is such a surge truly possible for this stock? - Bitget

Apr 02, 2026

Apr 01, 2026

How Shifting Margin Assumptions Are Rewriting The NeuroPace (NPCE) Investment Narrative - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com

Apr 01, 2026

Mar 31, 2026

NeuroPace Inc urges epilepsy patients to evaluate RNS System through online quiz - Traders Union

Mar 31, 2026

Mar 27, 2026

Global Neuromodulation Closed-Loop Brain-Computer Interfaces Market Set for 16.4% CAGR Surge Through 2036, Led by the United States, India & China; Key Players Medtronic, NeuroPace, Synchron Drive Algorithm-Centric Innovation - Morningstar

Mar 27, 2026

Mar 25, 2026

NeuroPace (NPCE) CMO has 1,341 shares withheld for RSU tax - stocktitan.net

Mar 25, 2026

Mar 25, 2026

Aug Selloffs: What makes NeuroPace Inc stock attractive todayMarket Weekly Review & Weekly High Momentum Picks - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Director at NeuroPace (NPCE) receives 913-share stock grant and controls large fund stake - Stock Titan

Mar 24, 2026

Mar 24, 2026

NeuroPace director granted 865 shares at $13 | NPCE Insider Trading - Stock Titan

Mar 24, 2026

Mar 23, 2026

NeuroPace (NPCE) director gets 1,153-share stock grant as board fees - Stock Titan

Mar 23, 2026

Mar 23, 2026

NeuroPace (NPCE) director receives 1,826-share equity grant in lieu of cash fees - Stock Titan

Mar 23, 2026

Mar 21, 2026

NeuroPace, Inc. (NPCE) may report negative earnings: Know the trend ahead of next week's release - MSN

Mar 21, 2026

Mar 20, 2026

Discipline and Rules-Based Execution in NPCE Response - Stock Traders Daily

Mar 20, 2026

Mar 19, 2026

Analysts Are Bullish on These Healthcare Stocks: Kestra Medical Technologies Ltd. (KMTS), NeuroPace (NPCE) - The Globe and Mail

Mar 19, 2026

Mar 19, 2026

NeuroPace (NASDAQ:NPCE) Upgraded at Wells Fargo & Company - MarketBeat

Mar 19, 2026

Mar 18, 2026

Wells Fargo Upgrades NeuroPace(NPCE.US) to Buy Rating, Raises Target Price to $19 - Moomoo

Mar 18, 2026

Mar 18, 2026

How The NeuroPace (NPCE) Story Is Shifting As Analysts Refresh Valuation Assumptions - Yahoo Finance

Mar 18, 2026

Mar 15, 2026

NeuroPace (NASDAQ:NPCE) Stock Rating Lowered by Wall Street Zen - marketbeat.com

Mar 15, 2026

Mar 14, 2026

NPCE SEC FilingsNeuropace Inc 10-K, 10-Q, 8-K Forms - stocktitan.net

Mar 14, 2026

Mar 12, 2026

NeuroPace falls after setback in trial for neuromodulation system - MSN

Mar 12, 2026

Mar 11, 2026

Published on: 2026-03-12 04:41:05 - baoquankhu1.vn

Mar 11, 2026

Mar 11, 2026

NeuroPace at Leerink Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

Mar 11, 2026

Mar 10, 2026

Key Factors Expected to Influence NPCE Stock Performance in 2026 - Bitget

Mar 10, 2026

Mar 10, 2026

Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026 - TradingView

Mar 10, 2026

Mar 10, 2026

NPCE RNS System Explained: Growth Drivers and Setup for 2026 - TradingView

Mar 10, 2026

Mar 10, 2026

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand - Yahoo Finance

Mar 10, 2026

Mar 09, 2026

Neuropace (NPCE) chief medical officer sells $399k in stock - Investing.com Nigeria

Mar 09, 2026

Mar 09, 2026

Behavioral Patterns of NPCE and Institutional Flows - Stock Traders Daily

Mar 09, 2026

Mar 08, 2026

Published on: 2026-03-09 06:34:24 - baoquankhu1.vn

Mar 08, 2026

Mar 07, 2026

NeuroPace appoints Patrick Williams as CFO - MSN

Mar 07, 2026

Mar 07, 2026

Market Outlook: Will NeuroPace Inc stock benefit from M AJuly 2025 Technicals & Technical Buy Zone Confirmation - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

NeuroPace (NASDAQ:NPCE) Upgraded to "Buy" at Wall Street Zen - MarketBeat

Mar 07, 2026

Mar 07, 2026

Rate Cut: Will NeuroPace Inc stock benefit from M AEarnings Recap Summary & Long Hold Capital Preservation Plans - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

Gains Recap: Is NeuroPace Inc a stock for growth or value investorsJuly 2025 WrapUp & Community Trade Idea Sharing - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access - The Globe and Mail

Mar 06, 2026

Mar 05, 2026

NeuroPace to Present at the Leerink Global Healthcare Conference - Investing News Network

Mar 05, 2026

Mar 05, 2026

NeuroPace revenue up 24% to USD 26.6M in Q4 2025 - Medical Buyer

Mar 05, 2026

Mar 05, 2026

Boston Scientific to buy Penumbra in $14.5 billion deal - AOL.com

Mar 05, 2026

Mar 05, 2026

NeuroPace (NASDAQ:NPCE) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat

Mar 05, 2026

Mar 04, 2026

NeuroPace (NPCE) Loss Narrowing In Q4 Tests Bullish Profitability Narrative - simplywall.st

Mar 04, 2026

Mar 04, 2026

NeuroPace (NPCE) CMO sells shares under Rule 10b5-1 trading plan - Stock Titan

Mar 04, 2026